Staar Surgical Co (STAA) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
the bull case· 2
197
of managers reporting a position in filings
13fJun 30 '26+11.16%
change in shares held by the largest reporting managers over the latest quarter
13fJun 30 '26the bear case· 4
6 of 8
in recent reports where the move came in under the options implied range
earnings historyimplied vs realized0.03%
of iShares Russell ETF's assets as the largest fund weight on file
n-portJun 30 '267 of 22
of the largest reporting managers cut their stake in the latest quarter
13fJun 30 '2613
managers whose positions together make up most of the reported value
13fJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 3 '26 report. Not a forecast, not advice.
Of the 6 companies Staar Surgical Co moves with most closely, none share its SEC classification.
Measured against 500 trading days of our own closes. Co-movement, not cause.
SIC 3851, Ophthalmic Goods, from each company's own filings. Largest first.
197 managers report a position worth $1.6B between them, and 13 of them hold 80% of it.
tall tick = annual report · 1 on record
High 21.21 at 9:30 am ET, low 20.56 at 3:15 pm ET.
Staar Surgical Co
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Ophthalmic Goods
STAA (Staar Surgical Co) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.